Trial setup and testing in adults with pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests new “trial tools” and designs for running early research in people with pulmonary hypertension. If you qualify, you may be asked to do extra trial-related procedures to help researchers test the process safely and smoothly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have a diagnosis of pulmonary hypertension (Groups 1, 2, 3, or 4)
- Your kidney function is adequate (eGFR over 25)
- Your body mass index (BMI) is under 35
- The main artery branch used for imaging/measuring is about 7 mm (as judged by the study)
- If you can become pregnant, you have a negative pregnancy test and you can consent in writing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses data from standard heart tests to develop a better way to detect pulmonary hypertension, a condition of high blood pressure in the lungs. It aims to help doctors diagnose this condition earlier and more accurately.
This study tests an investigational drug (HS235) for people who have both heart failure with preserved ejection fraction and a type of pulmonary hypertension that can happen with it. The goal is to see if the drug can improve symptoms and quality of life.
This trial tests whether a structured exercise program, done with remote support, is safe and helpful for children with pulmonary hypertension. It aims to improve how well kids function day-to-day while they stay on their usual PH medications.
This study checks how safe pulmonary hypertension–targeted medicines (and some calcium-blocking medicines) are over time. It uses a computer system to follow you after diagnosis, looking at outcomes and side effects.
This trial studies an implanted system (the Aria CV Pulmonary Hypertension System) to treat pulmonary arterial hypertension, a serious lung-blood vessel and heart condition. It aims to see whether the device can improve outcomes for people who are still sick despite existing PH medicines.
This study tests whether a home-based exercise program, guided by a smartphone app, can improve your daily life and heart function if you have pulmonary hypertension. You will use a wearable device to track your activity and receive remote support from a medical team.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.